Page last updated: 2024-11-09

aflatoxin g2

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID2724362
CHEBI ID80705
MeSH IDM0094698

Synonyms (33)

Synonym
7241-98-7
ccris 4936
3,4,7aalpha,9,10,10aalpha-hexahydro-5-methoxy-1h,12h-furo(3',2':4,5)furo(2,3-h)pyrano(3,4-c)(1)-benzopyran-1,12-dione
hsdb 3456
einecs 230-643-4
(7ar,cis)3,4,7a,9,10,10a-hexahydro-5-methoxy-1h,12h-furo(3',2':4,5)furo(2,3-h)pyrano(3,4-c)chromene-1,12-dione
1h,12h-furo(3',2':4,5)furo(2,3-h)pyrano(3,4-c)(1)benzopyran-1,12-dione, 3,4,7a-alpha,9,10,10a-alpha-hexahydro-5-methoxy-
1h,12h-furo(3',2':4,5)furo(2,3-h)pyrano(3,4-c)(1)benzopyran-1,12-dione,3,4,7aalpha,9,10,10aalpha-hexahydro-5-methoxy-
aflatoxin g2
C16754
unii-2ms0d8wa29
1h,12h-furo(3',2':4,5)furo(2,3-h)pyrano(3,4-c)(1)benzopyran-1,12-dione, 3,4,7a,9,10,10a-hexahydro-5-methoxy-, (7ar,10as)-
2ms0d8wa29 ,
1h,12h-furo(3',2':4,5)furo(2,3-h)pyrano(3,4-c)(1)benzopyran- 1,12-dione, 3,4,7a,9,10,10a-hexahydro-5-methoxy-, (7ar,10as)-
aflatoxin g2 [hsdb]
aflatoxin g2 [mi]
(7ar,cis)3,4,7a,9,10,10a-hexahydro-5-methoxy-1h,12h- furo(3',2':4,5)furo(2,3-h)pyrano(3,4-c)chromene-1,12-dione
CHEBI:80705
aflatoxing2
mfcd00078141
1h,12h-furo[3',2':4,5]furo[2,3-h]pyrano[3,4-c][1]benzopyran-1,12-dione, 3,4,7a,9,10,10a-hexahydro-5-
aflatoxin g2, from aspergillus flavus, >=98.0% (hplc/tlc)
aflatoxin g2, reference material
(7ar,10as)-5-methoxy-3,4,7a,9,10,10a-hexahydro-1h,12h-furo[3',2':4,5]furo[2,3-h]pyrano[3,4-c]chromene-1,12-dione
DTXSID80891796
Q26841280
EX-A4123
(7ar-cis)-3,4,7a,9,10,10a-hexahydro-5-methoxy-1h,12h-furo[3',2':4,5]furo[2,3-h]pyrano[3,4-c][1]benzopyran-1,12-dione
CS-0099736
HY-N6698
aflatoxin g2 0.5 microg/ml in acetonitrile
(3s,7r)-11-methoxy-6,8,16,20-tetraoxapentacyclo[10.8.0.02,9.03,7.013,18]icosa-1,9,11,13(18)-tetraene-17,19-dione
aflatoxin g2 in acetonitrile
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
coumarins
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
aflatoxins B2 and G2 biosynthesis313

Research

Studies (80)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (17.50)18.7374
1990's12 (15.00)18.2507
2000's22 (27.50)29.6817
2010's29 (36.25)24.3611
2020's3 (3.75)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (0.97%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other102 (99.03%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]